Cost-utility analysis of life-long prophylaxis with recombinant factor VIIIFc vs recombinant factor VIII for the management of severe
hemophilia A in Sweden.
Patients suffering from
hemophilia A has a mutation for factor VIII in the gene and patients suffering from hemophilia B have a mutation due to the absence of clotting factor IX.
The "Hemophilia Market Analysis By Type (
Hemophilia A, Hemophilia B, Hemophilia C), By Treatment (On-demand, Prophylaxis), By Therapy (Replacement Therapy, Immune Tolerance Induction [ITI]Therapy, Gene Therapy), And Segment Forecasts to 2024" report has been added to ResearchAndMarkets.com's offering.
[ClickPress, Thu Jul 04 2019] Manufacturers such as Roche has recently acquired Spark Therapeutics for its long term investment
hemophilia A gene therapy market.
There are two types of diseases like
hemophilia A and hemophilia B, he said adding that the disease can transform into boy babies from their mothers.
M2 PHARMA-February 4, 2019-Chugai's Hemlibra Gains Positive CHMP Opinion in Severe
Hemophilia a Without Inhibitors
is the number of live male births diagnosed with
hemophilia A.
M2 EQUITYBITES-September 3, 2018-Bayer passes US FDA's approval for Jivi for the routine prophylactic treatment of
hemophilia AGlobal Banking News-September 3, 2018-Bayer passes US FDA's approval for Jivi for the routine prophylactic treatment of
hemophilia APatients with known bleeding disorders other than
Hemophilia A, liver disease, co morbid and using aspiring were excluded from the study.
Genentech, a member of the Roche Group, announced that pivotal data from the Phase III HAVEN 3 study, which evaluated HEMLIBRA prophylaxis administered every week or every two weeks in adults and adolescents aged 12 years or older with
hemophilia A without factor VIII inhibitors, were published in the August 30, 2018, issue of the New England Journal of Medicine.